Trials / Completed
CompletedNCT00251901
Chest Pain Pilot Study
A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 mg Bid for 4 Weeks.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 600 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of Nexium® with placebo in relief of acid related pain or discomfort in the chest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2005-07-01
- Completion
- 2005-07-01
- First posted
- 2005-11-11
- Last updated
- 2011-01-24
Locations
80 sites across 6 countries: Canada, Denmark, Germany, Netherlands, Norway, Sweden
Source: ClinicalTrials.gov record NCT00251901. Inclusion in this directory is not an endorsement.